ID2 and Ewing sarcoma: This result suggested that downregulation of Id2 protein expression observed in Ewing's sarcoma cell lines upon treatment with ZSTK474 could be mediated via transcriptional inactivation of EWSR1-FLI1 from the Id2 promoter.